AN2 Therapeutics, Inc. (ANTX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$4.88−$0.0100 (−0.20%) on the dayAs of the close; data may be delayed.
ANTX price, last 12 months
Key stats
- Previous close
- $4.89
- Open
- $4.91
- Day range
- $4.71 – $4.95
- 52-week range
- $1.00 – $7.19
- Volume
- 155.1K
- Avg volume (20 days)
- 233.2K
- Market cap
- $184.2M
Performance
1W−3.4%
1M−11.8%
3M−6.2%
6M+35.2%
YTD+328.1%
1Y+282.8%
vs S&P 500, 1Y+266.0 pts
Technicals and fundamentals
About AN2 Therapeutics, Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $184.2M